Allelic variation at the interleukin 1 β gene is associated with decreased bone mass in patients with inflammatory bowel diseases

Gut

Volumn 49, Issue 5, 2001, Pages 644-649

  Nemetz, A ^a   Toth M ^a   Garcia Gonzalez M A ^b   Zagoni T ^a   Feher J ^a   Pena A S ^b   Tulassay, Z ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Bone density; Crohn's disease; Genetic polymorphisms; Inflammatory bowel diseases; Interleukin 1; Osteoporosis; Ulcerative colitis

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA;

ADULT; ALLELE; ARTICLE; BONE ATROPHY; BONE DENSITY; BONE MASS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENSITOMETRY; DISEASE ASSOCIATION; ENTERITIS; FEMALE; FEMUR NECK; GENETIC POLYMORPHISM; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; OSSIFICATION; OSTEOCLAST; OSTEOPENIA; OSTEOPOROSIS; PATHOGENESIS; PRIORITY JOURNAL; RADIUS; RISK FACTOR; TANDEM REPEAT;

ADULT; ALLELES; ANALYSIS OF VARIANCE; BONE DENSITY; CASE-CONTROL STUDIES; DENSITOMETRY, X-RAY; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-1; MALE; OSTEOPOROSIS; POLYMORPHISM, GENETIC; RECEPTORS, INTERLEUKIN-1; TANDEM REPEAT SEQUENCES; VARIATION (GENETICS);

EID: 0034776454     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.49.5.644     Document Type: Article

References (49)

1. Osteoporosis in patients with inflammatory bowel disease
2. Interleukin-1 and tumour necrosis factor stimulate the formation of human osteoclast-like cells in vitro
3. Effects of interferon-gamma and other cytokines on collagen synthesis in fetal rat bone cultures
4. Simultaneous block of interleukin-1 and tumour necrosis factor is required to completely prevent bone loss in the early postovariectomy period
5. Cytokine production and bone mineral density at the lumbar spine and femoral neck in premenopausal women
6. Spontaneous release of interleukin 1 from human blood monocytes reflects bone formation in idiopathic osteoporosis
7. Cytokine production in patients with inflammatory bowel disease
8. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation
9. Relationship of interleukin-1 receptor antagonist to mucosal inflammation in inflammatory bowel disease
10. Mucosal inflammatory cytokine production by intestinal biopsies in patients with ulcerative colitis and Crohn's disease
11. Reduced bone density in patients with inflammatory bowel disease
12. Bone mass is low in relatives of osteoporotic patients
13. Determinants of bone mass in 10- to 26-year-old females: A twin study
14. Racial differences in hip axis lengths might explain racial differences in rates of hip fracture. Study of Osteoporotic Fractures Research Group
15. Genetic factors in bone turnover
16. Prediction of bone density from vitamin D receptor alleles
17. Association of bone mineral density with polymorphism of the estrogen receptor gene
18. A sequence variation: 713-8delC in the transforming growth factorbeta 1 gene has higher prevalence in osteoporotic women than in normal women and is associated with very low bone mass in osteoporotic women and increased bone turnover in both osteoporotic and normal women
19. Reduced bone density and osteoporosis associated with a polymorphic Sp 1 binding site in the collagen type I alpha 1 gene
20. Are vitamin D receptor polymorphisms associated with bone mineral density? A meta-analysis
21. Nonassociation of estrogen receptor genotypes with bone mineral density, and estrogen responsiveness to hormone replacement therapy in Korean postmenopausal women
22. Allelic variation at the interleukin-1 receptor antagonist gene is associated with early postmenopausal bone loss at the spine
23. Combined sib-TDT and TDT provide evidence for linkage of the interleukin-1 gene cluster to erosive rheumatoid arthritis
24. Cytokine production by normal human monocytes: Inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism
25. Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro
26. IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1beta genes
27. IL-1 beta gene polymorphisms influence the course and severity, of inflammatory bowel disease
28. Classification of inflammatory bowel disease
29. A simple classification of Crohn's disease; Report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998
30. Single base polymorphism at -511 in the human interleukin-1 beta gene (IL1 beta)
31. A TaqI polymorphism in the human interleukin-1β (IL-1β) gene correlates with IL- 1β secretion in vitro
32. Allelic polymorphism in IL-1 beta and IL-1 receptor antagonist (IL-1Ra) genes in inflammatory bowel disease
33. Significant differences in the interleukin-1 beta and interleukin-1 receptor antagonist gene polymorphisms in a Hungarian population with inflammatory bowel disease
34. A controlled study of bone mineral density in patients with inflammatory bowel disease
35. Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: A population based study
36. Femoral neck osteopenia in patients with inflammatory bowel disease
37. Increased degradation of type I collagen in patients with inflammatory bowel disease
38. Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease
39. The interleukin-1 genotype as a severity factor in adult periodontal disease
40. Interleukin-1beta+3953 allele 2: Association with disease status in adult periodontitis
41. An interleukin 1B allele, which correlates with a high secretor phenotype, is associated with diabetic nephropathy
42. Polymorphisms of the interleukin-1 gene complex in schizophrenia
43. Interleukin-1 polymorphisms associated with increased risk of gastric cancer
44. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man
45. Mice lacking the type I interleukin-1 receptor do not lose bone mass after ovariectomy
46. A unitary model for involutional osteoporosis: Estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men
47. Estrogen's boneprotective effects may involve differential IL-1 receptor regulation in human osteoclast-like cells
48. Low bone mineral density in Crohn's disease, but not in ulcerative colitis at diagnosis
49. Genetic factors determine extent of bone loss in inflammatory bowel disease